Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing

Leukemia. 2016 Apr;30(4):966-70. doi: 10.1038/leu.2015.198. Epub 2015 Jul 23.

Authors

N Cervera¹, N Carbuccia¹, S Garnier¹, A Guille¹, J Adélaïde¹, A Murati^{1

2}, N Vey^{3

4}, M-J Mozziconacci^{1

2}, M Chaffanet^{1

3}, D Birnbaum^{1

3}, V Gelsi-Boyer^{1

2

3}

Affiliations

¹ Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes, CNRS UMR725, Marseille, France.
² Département de BioPathologie, Institut Paoli-Calmettes, Marseille, France.
³ Aix-Marseille Université, Marseille, France.
⁴ Département d'Hématologie, Institut Paoli-Calmettes, Marseille, France.

PMID: 26202927
DOI: 10.1038/leu.2015.198

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / genetics*
Chromosome Aberrations*
Female
High-Throughput Nucleotide Sequencing / methods*
Humans
Leukemia, Erythroblastic, Acute / genetics*
Leukemia, Erythroblastic, Acute / mortality
Leukemia, Erythroblastic, Acute / pathology
Male
Middle Aged
Mutation / genetics*
Neoplasm Staging
Prognosis
Survival Rate

Substances

Biomarkers, Tumor